3Kobayashi H. Interim results from a multi-centre clinical trial of T-3761 in Japan[J]. Drug, 1995, 49 (Suppl 2) : 470-471.
4Domagala JM. Structure-activity and structure-side effect relationships for the quinolone antibacterials[ J]. J Antimicrob Chemother, 1994, 33(4) :685.
5Takayama S, Hirohashi M, Kato M, et al. Toxicity of quinolone antimierobial agents [J].J Tox Environ Health, 1995, 45(1) :145.
